Product Images Topiramate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Topiramate NDC 43063-612 by Pd-rx Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
TOPIRAMATE is a medication available in the form of tablets, each containing 50mg of the active ingredient. The package contains 60 tablets with a yellow color and round shape. The medication is meant to be taken according to the doctor's instructions. The package details include the NDC number- 43063-612-60, ReOrder number- 109041, Lot number, and Expiration date. The medication should be taken as per the doctor's advice as it may cause side effects. Call your doctor immediately in case of any severe side effects, and they can also be reported to the FDA.*
The text describes a graph showing the cumulative rates for time to the first seizure for two groups receiving different dosages of topiramate (50 mg/day and 400 mg/day). The x-axis represents time in days, while the y-axis represents the cumulative rate. There are five points on the y-axis ranging from 0.1 to 0.5. The graph has two lines, one for each group, represented by different symbols, and the sample sizes (N) are shown.*
The text is a table showing the change in the average monthly migraine period rate with different doses of Topiramate compared to Placebo. The table shows the sample sizes and indicates that the data is from Study 10 and Study 11. The asterisks next to the values suggest that there is a significant difference between the groups.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.